CAP Smart Takes Vol. 01

CAP Smart Takes Vol. 01

In this volume, you will find information regarding the safety and efficacy of agomelatine for youth with MDD, the safety and efficacy of SGAs for bipolar depression, and a debate on the knowns and unknowns of SSRI treatment in this population. Also, can extended-release methylphenidate compounds be used in very young children? And what are the factors associated with stimulant treatment outcomes?

  • Provider:Medical Academy, LLC
  • Activity Link: https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-01-2740?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
  • Start Date: 2022-09-28 05:00:00
  • End Date: 2022-09-28 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Limited
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.